CSTL

Castle Biosciences
$24.44
−$0.24 (−0.99%)Jul 27, 2026
5.2NeutralMoatMint rating

MoatMint rates Castle Biosciences (CSTL) 5.2 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 5.3 out of 10.

Key metrics

The numbers that frame CSTL today
Market cap
$741.26M
P/E (TTM)
-57.8
EV / FCF
156.6
Gross margin
77.9%
EV / Sales
2.1
ROIC
-5%
Div yield
0%
Debt / equity
0.1
52wk Low
$14.59
52wk High
$44.28

CSTL stock rating

How CSTL scores on quality, value, growth, momentum and financial health
5.2out of 10
Neutral overallHealthy business, full priceTop 48% of ~5,000 US stocks
QualityNeutral5.3/10
GrowthGreat9.0/10
MomentumNeutral4.2/10
ValueNeutral4.1/10
Financial HealthNeutral4.7/10

Growth

Revenue and earnings trend for CSTL
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about CSTL
Is Castle Biosciences a good buy?
Hold. Castle Biosciences has mixed quality and weak momentum. The setup is mixed. Growth looks excellent, which supports the long-term business case. We think Castle Biosciences is selling at a high price.
What is the market capitalization of CSTL?
Castle Biosciences's market capitalization is $741.26M.
What is the P/E ratio for CSTL stock?
Castle Biosciences's current P/E ratio is -57.8.
What is the 52-week high for CSTL stock?
The 52-week high for Castle Biosciences is $44.28. The current close of $24.44 is 44.8% below that high.
What is the 52-week low for CSTL stock?
The 52-week low for Castle Biosciences is $14.59. The current close of $24.44 is 67.5% above that low.
Does CSTL stock pay dividends?
Castle Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CSTL?
Castle Biosciences's Debt / Equity ratio is 0.08.